These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3016067)

  • 1. Specific allergen-induced Epstein-Barr nuclear antigen-positive B cells from patients with chronic-active Epstein-Barr virus infections.
    Olson GB; Kanaan MN; Kelley LM; Jones JF
    J Allergy Clin Immunol; 1986 Aug; 78(2):315-20. PubMed ID: 3016067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between allergy and persistent Epstein-Barr virus infections in chronic-active Epstein-Barr virus-infected patients.
    Olson GB; Kanaan MN; Gersuk GM; Kelley LM; Jones JF
    J Allergy Clin Immunol; 1986 Aug; 78(2):308-14. PubMed ID: 3016066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus susceptibility of normal human B lymphocyte populations.
    Aman P; Ehlin-Henriksson B; Klein G
    J Exp Med; 1984 Jan; 159(1):208-20. PubMed ID: 6319530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus and rheumatoid arthritis.
    Bluestein HG; Hasler F
    Surv Immunol Res; 1984; 3(1):70-7. PubMed ID: 6326237
    [No Abstract]   [Full Text] [Related]  

  • 5. Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance.
    Khanna R; Burrows SR; Steigerwald-Mullen PM; Thomson SA; Kurilla MG; Moss DJ
    Virology; 1995 Dec; 214(2):633-7. PubMed ID: 8553567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Epstein-Barr virus nuclear antigens 3, 4, and 6 are altered in cell lines containing B-type virus.
    Sculley TB; Apolloni A; Stumm R; Moss DJ; Mueller-Lantczh N; Misko IS; Cooper DA
    Virology; 1989 Aug; 171(2):401-8. PubMed ID: 2548326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody responses to two Epstein-Barr virus nuclear antigens defined by gene transfer.
    Miller G; Grogan E; Fischer DK; Niederman JC; Schooley RT; Henle W; Lenoir G; Liu CR
    N Engl J Med; 1985 Mar; 312(12):750-5. PubMed ID: 2983211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blastogenic response and EBNA induction in human lymphocytes by Epstein-Barr virus only requires B cells but not macrophages.
    Gergely P; Ernberg I
    Cancer Lett; 1977 Mar; 2(4-5):217-20. PubMed ID: 45722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells.
    Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB
    Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus (EBV) antigens processed and presented by B cells, B blasts, and macrophages trigger T-cell-mediated inhibition of EBV-induced B-cell transformation.
    Bejarano MT; Masucci MG; Morgan A; Morein B; Klein G; Klein E
    J Virol; 1990 Mar; 64(3):1398-401. PubMed ID: 2154620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Epstein-Barr virus-specific cytotoxic T cell epitope in EBV nuclear antigen 3 (EBNA 3).
    Burrows SR; Sculley TB; Misko IS; Schmidt C; Moss DJ
    J Exp Med; 1990 Jan; 171(1):345-9. PubMed ID: 1688611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of antigen uptake and presentation by Epstein-Barr virus-transformed human lymphoblastoid B cells.
    Chu E; Umetsu D; Lareau M; Schneeberger E; Geha RS
    Eur J Immunol; 1984 Apr; 14(4):291-8. PubMed ID: 6327319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cells specific for different latent and lytic viral proteins efficiently control Epstein-Barr virus-transformed B cells.
    Nowakowska J; Stuehler C; Egli A; Battegay M; Rauser G; Bantug GR; Brander C; Hess C; Khanna N
    Cytotherapy; 2015 Sep; 17(9):1280-91. PubMed ID: 26276009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-barr-virus nuclear antigen.
    Vonka V; Hirsch I
    Prog Med Virol; 1982; 28():145-79. PubMed ID: 6283600
    [No Abstract]   [Full Text] [Related]  

  • 15. [EBV diseases].
    Weber J
    Monatsschr Kinderheilkd; 1986 Feb; 134(2):60-6. PubMed ID: 3010085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus-infected B cells of males with the X-linked lymphoproliferative syndrome stimulate and are susceptible to T-cell-mediated lysis.
    Jäger M; Benninger-Döring G; Prang N; Sylla BS; Laumbacher B; Wank R; Wolf H; Schwarzmann F
    Int J Cancer; 1998 May; 76(5):694-701. PubMed ID: 9610728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A positive correlation between the precursor frequency of cytotoxic lymphocytes to autologous Epstein-Barr virus-transformed B cells and antibody titer level against Epstein-Barr virus-associated nuclear antigen in healthy seropositive individuals.
    Kusunoki Y; Huang H; Fukuda Y; Ozaki K; Saito M; Hirai Y; Akiyama M
    Microbiol Immunol; 1993; 37(6):461-9. PubMed ID: 8231961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23.
    Wang F; Gregory CD; Rowe M; Rickinson AB; Wang D; Birkenbach M; Kikutani H; Kishimoto T; Kieff E
    Proc Natl Acad Sci U S A; 1987 May; 84(10):3452-6. PubMed ID: 3033649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-cell polyclonal activation and Epstein-Barr viral abortive lytic cycle are two key features in acute infectious mononucleosis.
    Al Tabaa Y; Tuaillon E; Jeziorski E; Ouedraogo DE; Bolloré K; Rubbo PA; Foulongne V; Rodière M; Vendrell JP
    J Clin Virol; 2011 Sep; 52(1):33-7. PubMed ID: 21684200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of variations in levels of Epstein-Barr Virus (EBV) antigen and adaptive immune response during chronic active EBV infection in children.
    Xing Y; Song HM; Wei M; Liu Y; Zhang YH; Gao L
    J Immunotoxicol; 2013; 10(4):387-92. PubMed ID: 23418935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.